The blood count is one of the most common tests used for health assessment. In elderly individuals, selection of a 'healthy' reference population for laboratory assessment is difficult due to the high prevalence of chronic morbidities, leading to uncertainty regarding appropriate reference intervals. In particular, age-specific lower haemoglobin reference limits to define anaemia are controversial. Here, we applied a data mining approach to a large dataset of 3 029 904 clinical routine samples to establish blood count reference intervals. We excluded samples from units/specialists with a high proportion of abnormal blood counts, samples from patients with an unknown or decreased estimated glomerular filtration rate, and samples with abnormal test results in selected other analytes. After sample exclusion, 566 775-572 060 samples from different individuals aged 20-100 years were available for analysis. We then used an established statistical algorithm to determine the distribution of physiological test results and calculated age-and sex-specific reference intervals. Our results show substantial trends with age in haematology analytes' reference intervals. Most notably, haemoglobin and red cell counts decline in men with advanced age, accompanied by increases in red cell volume in both sexes. These findings were confirmed in an independent dataset, and suggest an at least partly physiologic cause.
Summary
The blood count is one of the most common tests used for health assessment. In elderly individuals, selection of a 'healthy' reference population for laboratory assessment is difficult due to the high prevalence of chronic morbidities, leading to uncertainty regarding appropriate reference intervals. In particular, age-specific lower haemoglobin reference limits to define anaemia are controversial. Here, we applied a data mining approach to a large dataset of 3 029 904 clinical routine samples to establish blood count reference intervals. We excluded samples from units/specialists with a high proportion of abnormal blood counts, samples from patients with an unknown or decreased estimated glomerular filtration rate, and samples with abnormal test results in selected other analytes. After sample exclusion, 566 775-572 060 samples from different individuals aged 20-100 years were available for analysis. We then used an established statistical algorithm to determine the distribution of physiological test results and calculated age-and sex-specific reference intervals. Our results show substantial trends with age in haematology analytes' reference intervals. Most notably, haemoglobin and red cell counts decline in men with advanced age, accompanied by increases in red cell volume in both sexes. These findings were confirmed in an independent dataset, and suggest an at least partly physiologic cause.
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The blood count is one of the most common tests for health assessment with diagnostic and therapeutic implications for a multitude of common to rare and minor to life-threatening conditions. However, despite its frequent clinical use and importance and near-universal availability on the one hand, and an ageing population throughout the world on the other hand, uncertainty regarding appropriate reference intervals for older individuals still exists. In particular, age-specific lower reference limits for haemoglobin, which define anaemia, are controversial, despite substantial consequences for individual patients and considerable public health impact.
A major challenge when establishing reference intervals for individuals >50 years is the increasing proportion of chronic morbidities and medication with age, which leads to exclusion of these subjects from conventional reference interval studies (Adeli et al., 2015; R€ ohrig et al., 2018) . Based on these restrictions, data mining of age-specific reference intervals using laboratory test results collected from routine patient care can be considered a viable complement to conventional reference interval studies (Haeckel et al., 2017; Jones et al., 2018) . In contrast to the highly selected population of conventional approaches, a reference interval data mining approach uses exactly the 'real world' population to which the reference intervals are ultimately applied, while still excluding outliers. In addition, the necessity to obtain a patient history and perform a clinical examination restricts the number of individuals who can be recruited for a conventional reference sample, while the number of samples available using data mining is only limited by the amount of test results stored in laboratory information systems. However, great care must be taken to avoid an unwarranted shift or widening of reference intervals in populations with a high prevalence of slightly abnormal test results. In previous work, we have shown that establishment of haematology reference intervals using a sophisticated data mining approach (the reference limit estimator, RLE) is feasible, even in the challenging setting of a tertiary care centre and a high proportion of abnormal test results (Zierk et al., 2018 (Zierk et al., , 2019 . In short, this approach assumes a mixture of parametrically distributed samples from healthy individuals and pathologic samples.
From the dominant fraction of physiological test results, the distribution of non-pathological values can be estimated and used to define reference intervals (Arzideh et al., 2008 (Arzideh et al., , 2010 Zierk et al., 2018) . Only one sample per person is considered to prevent unwarranted over-representation of individuals, and to reduce the impact of patients with disease, who will receive more frequent blood tests than their healthier counterparts.
Here, we report on the establishment of sex-and agespecific reference intervals for individuals of 20-100 years of age for haematology analytes using the RLE on samples from a large laboratory service provider, and validation of the results in an independent dataset from a tertiary care centre. To explore the effect of increasing comorbidity with age on reference intervals, we apply different filtering criteria deduced directly from the laboratory dataset, and measure the age-specific proportion of test results classified as abnormal.
Materials and methods

Study population and selection of samples
We examined blood count measurements performed during routine care of patients and sent to a German laboratory service provider from 01/2012 to 06/2017 (Medizinisches Versorgungszentrum Labor Volkmann, Karlsruhe, Germany). To comply with privacy regulations and ethical considerations, samples were anonymized before data transfer and analysis. Additionally, we examined measurements performed during patient care in the University Hospital Erlangen (Germany) from 01/2013 to 12/2018 to assess the reproducibility of the performed analyses in a tertiary care setting. The influence of renal function and inflammation/acute-phase reactions was assessed by examination of C-reactive protein (CRP) and creatinine concentrations within three days (CRP) and seven days (creatinine) of blood count measurements (if multiple CRP or creatinine measurements were available within the specified time-frame, the maximum concentration was used; see Sample exclusion below for details).
Laboratory test results from inpatients and outpatients aged 20-100 years were retrieved from the laboratory databases. Test results from units/specialists with a supposedly high proportion of patients with severe diseases affecting haematology analytes were excluded from the analysis (Table I) . The investigated patient population is composed predominantly of Caucasian individuals. Ethnicity of patients was not available in the dataset and no stratification according to ethnicity was performed.
Analytical procedures
We analyzed measurements of haemoglobin, haematocrit, red cell count, red cell indices (mean corpuscular haemoglobin, MCH; mean corpuscular haemoglobin concentration, MCHC; mean corpuscular volume, MCV, platelet count, and white cell count). Haematology analyses were performed on Sysmex (Norderstedt, Germany) XE and XM devices (Labor Volkmann) and Sysmex XE 5000 and XT 2000i devices (University Hospital Erlangen); CRP and creatinine were measured on Roche Diagnostics (Mannheim, Germany) Cobas 8000 devices (Labor Volkmann) and Beckman Coulter Diagnostics (Krefeld, Germany) AU5800 and AU680 devices (University Hospital Erlangen), in accordance with standard operating procedures. Creatinine measurements were performed using a method traceable to reference isotope dilution mass spectroscopy (IDMS). Regular quality control according to German regulations was performed.
Sample selection
Reference intervals were calculated for different age groups (≥20 years to <30 years, ≥30 years to <40 years, . . ., ≥90 years to <100 years) for men and women. When multiple samples from a single individual in an age group existed, a random sample from that individual was examined. This strategy has proven equivalent in comparison to more complex sample selection strategies, which try to account for the frequency of sampling as a surrogate for 'clinical grounds for retesting' (e.g. selection of the sample 'most isolated in time', i.e. no repeat measurements before or after the sample) in a previous analysis (Zierk et al., 2018) .
Calculation of reference intervals
Reference intervals were calculated with an indirect algorithm described and validated previously (Arzideh et al., 2008 (Arzideh et al., , 2010 Zierk et al., 2018) 
Sample exclusion
Before the determination of reference intervals with the algorithm outlined above, samples were excluded according to the following criteria ( Fig 1) : 
Statistical testing of trends of reference intervals with age and differences between sexes
We used the Mann-Kendall test to test for significant changes with age in the percentiles (2.5th, 50th, and 97.5th percentile) and widths of reference intervals. This was performed for all age groups (20-30 years to 90-100 years) and for elderly age groups (50-60 to 90-100 years), to account for continuous changes starting early as well as for changes with a later onset.
To estimate the change with age per decade of life, we used Theil-Sen regression. Differences in reference intervals between men and women were tested using the sign test (all age groups' men's 2.5th and 97.5th percentiles versus all women's 2.5th and 97.5th percentiles). All statistical tests were performed using Python (Python Software Foundation, https:// www.python.org/) and the scikit-learn (Pedregosa et al., 2011) and pymannkendall (Hussain & Mahmud, 2019) libraries.
Results
We collected 3 029 904 samples from 850 013 different individuals. After exclusion of test results according to requesting unit/specialist (Table I) , 2 836 098 samples from 788 112 different individuals remained.
Effect of different sample exclusion strategies on agespecific reference intervals
Exclusion of samples with different filtering strategies, based on CRP, creatinine, estimated glomerular filtration rate (eGFR), and test results in other blood count analytes (Fig 1) substantially reduced the number of samples in an age- available. The effect of sex, age, and sample exclusion strategy on the different analytes' reference intervals is shown in Fig 2 and Figure S1 . Haemoglobin, haematocrit, and red cell count reference intervals decrease with age in a sex-specific manner (i.e. more pronounced in men than in women). The decrease in age-specific lower reference limits was less pronounced when stricter filtering was applied. Similarly, MCV and MCH reference intervals increase with age and a more pronounced increase is observed in men, with narrower reference intervals in stricter sample exclusion strategies. For platelet counts and white cell counts, age-specific changes in reference intervals are substantially less distinctive, but reference intervals are narrower with stricter filtering. We decided from these results to use the data derived from the strictest sample preselection strategy (i.e., the healthiest population 'D4') for the definition of reference intervals.
Age-and sex-specific reference intervals
Reference intervals established using the strictest sample selection strategy D4 are shown in Fig 3 and Table II . These results show a decrease of sex-specific differences of haemoglobin, haematocrit, and red cell count reference intervals with age. Men's haemoglobin, haematocrit, and red cell count reference intervals decline continuously with age (P < 0Á001, see Table SI ), both in lower and upper reference interval limits and in reference interval medians. Changes in women start later and are less pronounced (significant decreases in women's haemoglobin reference intervals after 50 years, P < 0Á05). On the contrary, sex-specific differences in MCH, MCHC and platelet count reference intervals remained relatively stable with age. MCV upper reference limits and medians increase with age in men and women (P < 0Á001). White cell count reference intervals show no substantial sex-specific differences (see Table SII ) and a slight decrease of upper reference values with increasing age in women (P < 0Á05). Platelet counts are higher in women than in men (P < 0Á001), and lower reference limits decrease slightly with age in both sexes (P < 0Á05).
Proportion of samples outside the generated reference intervals
The proportion of test results within our primary dataset D0 outside the reference intervals calculated as described above is shown in Fig 4. A marked increase with age in the proportion of test results classified as abnormal despite the shift of reference intervals described above can be observed for haemoglobin, haematocrit, and red cell counts, particularly for men aged 60-90 years. For platelets, a similar, albeit less substantial increase of abnormal test results can be observed (mainly due to thrombocytopenia), while for red cell indices and white cell counts, we observed no clear age-specific trends in the fraction of measurements classified as pathologic.
Reproducibility of reference intervals in a tertiary care centre
To show that the established results are not specific to the primary dataset from a German laboratory service provider, we examined a second dataset from a German tertiary care 
Discussion
Conventional strategies to define reference intervals require the acquisition of a sufficient number of samples from a healthy reference population. If reference intervals change with sex and age, the number of samples necessary is multiplied by the number of cohorts of interest. In elderly patients, recruitment of 'healthy' individuals poses additional challenges due to the high prevalence of chronic diseases and prescription medication: exclusion of individuals according to these criteria leads to the selection of the 'most healthy minority', with questionable appropriateness of resulting reference intervals for the general population, and substantial practical obstacles when recruiting reference individuals. We Effect of different filtering strategies on age-specific reference intervals. Bars show the age-specific reference intervals for different filters, with increasing selectivity for each age group [from left to right/white to black: (1., reference intervals D0 in Fig 1) no filter, (2., reference intervals D3) exclusion according to test results below the first or above the 99. percentile in other analytes, (3., reference intervals D1) exclusion according to creatinine and Creactive protein (CRP), (4., reference intervals D2) exclusion according to CRP, and inclusion only of patients with eGFR (MDRD) ≥60 ml/ min 9 1Á73 m 2 , and (5., reference intervals D4) combination of all filters/final reference intervals]. See Figure S1 for results in other analytes. MCV, mean corpuscular volume. circumvented these problems by using a data mining approach and applying an algorithm (Arzideh et al., 2011) , that has been successfully used to evaluate paediatric (Zierk et al., 2013 (Zierk et al., , 2015 (Zierk et al., , 2019 and adult (Zierk et al., 2018) reference intervals in haematology, with the aim to define ageand sex-specific reference intervals in the elderly. We did not collect any medical histories, but, starting with two very large datasets of routine clinical samples, we removed pathological samples in a five-step process: (i) we excluded units and specialists caring for patients with a high expected fraction of haematologic abnormalities, (ii) we removed samples from patients with reduced renal function or acute-phase reaction, (iii) we excluded samples with clearly abnormal test results in the same sample in other haematology analytes, (iv) we selected only one sample per patient, thereby reducing overrepresentation of samples from chronically and critically ill patients, and (v) we calculated the distribution of physiologic measurements using an established algorithm (RLE), separating them from pathologic test results. Using this approach, we can support our findings on sample numbers for each age-and sex-specific cohort that are by magnitudes larger than available with conventional strategies, and that recruit participants using medical histories and clinical examinations (Cheng et al., 2004; Adeli et al., 2015; R€ ohrig et al., 2018; Fulgoni et al., 2019) . The validity of the reference intervals reported in this manuscript is supported by the largely similar results from two independent cohorts within this work, by the concordance of the results of the middle-aged populations with previous data from others (Pekelharing et al., 2010; Ambayya et al., 2014; Adeli et al., 2015; Koerbin et al., 2017; Ozarda et al., 2017) and from our hospital using a different dataset measured with different haematology analysers in a previous study (Zierk et al., 2018) . Sample measurements in this study were performed using Sysmex haematology analysers; however, for the parameters described here, measurements from modern analysers are largely comparable, with subtle differences mainly for platelets, which are of minor clinical relevance from our point of view (Meintker et al., 2013; Bruegel et al., 2015; Zierk et al., 2018) . Since our results are derived from a mainly Caucasian population, it would be interesting to perform similar studies in populations with a different genetic background.
Platelet counts show clear sex-specific differences, with higher measurements in women. Upper reference limits are quite similar across ages, whereas lower limits slightly decrease with age. Due to the minor magnitude of the changes with age in comparison to intra-individual variation, we consider age-specific platelet count reference intervals not necessary from a practical point of view. For white cell counts, no clear sex-specific differences are observed, whereas a slight decline with increasing age in the upper reference limits was noted. This analyte was the only one with a marked difference between the two cohorts in our study: higher upper reference limits were calculated from the hospital cohort despite exclusion of patients with an elevated CRP. The differences between the two datasets can probably be explained by a higher fraction of patients with mild leucocytosis in the hospital dataset, e.g. due to mild immune activation not detected by CRP or due to stressif this is a frequent but very slight deviation, it is not completely captured by the RLE algorithm that has its strength in the detection of clearly abnormal measurements (Zierk et al., 2018) . From a practical point of view, we suggest the results for the outpatient cohort are applied without sex-and age-specific separation.
Age-and sex-related variation of erythrocyte parameters are of special interest. For the definition of anaemia, most authors use the World Health Organization (WHO) definitions of 120 g/l (women) and 130 g/l (men), without stratification by age in adults (WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968 ). However, the validity of these cut-off values (which have been developed more than 40 years ago by a WHO expert group) for older subjects is controversial (Beutler & Waalen, 2006) . Data from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2012 derived from 20 497 adults aged 20 to 79 years (41% exclusion rate from the primary population-based sample) shows decreasing haemoglobin reference intervals with age in men aged 20-79 years, while female reference intervals are essentially stable with a slight increase after menopause (Fulgoni et al., 2019) . Similar trends had been reported before from the earlier NHANES III data based on 6 472 samples from healthy adults (exclusion rate 62%) (Cheng et al., 2004) . The Canadian Health Measures Survey reports changes in reference intervals mainly in children. While 4 070 samples were available from individuals aged 15-79 years, 79 % of screened individuals aged 60-79 years old were excluded (Adeli et al., 2015; Horowitz, 2015) . This makes the judgement of specific changes in the elderly difficult, although, a slight increase of MCV and a decrease of haemoglobin in men can be observed with increasing age (Adeli et al., 2015) .
Overall, the reference intervals from the publications cited above are in accordance with our data regarding age-and sex-specific differences as well as absolute magnitudes. However, due to our different approach starting with routine data, we can calculate reference intervals from cohorts that are much larger and thus give a much more exact picture. In men, medians and upper and lower reference limits of haemoglobin, haematocrit and red cell count decrease with age. This change is most pronounced for red cell counts, because we observe a parallel increase in MCH and MCV. All of these changes occur in a continuous fashion between the ages of 30 and 90 years. In women, we see a slight rise of haemoglobin and haematocrit after menopause and a decline in the lower reference limits thereafter. In both sexes, we observe widening reference intervals in the elderly.
In contrast to our results and to the studies cited above, a 2018 report by R€ ohrig et al. shows reference intervals in the three age decades of individuals between 60 and 90 years old to be essentially identical and also similar to younger individuals in a study specifically devoted to analytes of erythropoiesis in the elderly (R€ ohrig et al., 2018) . These results have to be considered critically due to methodological aspects. As in other studies, patients were excluded based on history and laboratory indicators of disease. However, in this study samples were also excluded if any blood count test result was outside the normal range defined in a German guideline (https://www.onkopedia.com/de/onkopedia/guideli nes/eisenmangel-und-eisenmangelanaemie), i.e. haemoglobin from a sample was excluded from further analysis if the haematocrit from the same sample was not in the predefined normal range. Since haemoglobin, haematocrit and red cell count are tightly correlated, we consider this strategy misleading and biased towards the predefined reference intervals, pushing the remaining cohort artificially towards 'superhealthy' normal values.
Based on our results and in accordance with published data, we conclude that with increasing age, 'physiologic' values of erythropoiesis decline, as we observe in men, whereas in women this shift is counteracted by blood loss during menstruation and possibly additional hormonal effects, leading to lower values in younger age, followed by a slight rise after menopause with a final drop of lower haemoglobin reference intervals in women >80 years.
These findings are in line with the current understanding of the physiology and pathophysiology of haematopoietic stem cell (HSC) ageing (Groarke & Young, 2019) : Although the number of HSCs increases in the elderly and their differentiation is skewed towards myeloid progenitors, these stem cells show reduced regenerative capacity and loss in function (Geiger et al., 2013) . Increasing levels of erythropoietin are believed to partly compensate for decreased erythropoietin sensitivity (Ershler et al., 2005) , and overall erythroid cell output of aged HSCs is substantially reduced (Geiger et al., 2013; Chung & Park, 2017) . The age-specific reference intervals reported by us reflect these established physiologic effects of ageing. Importantly, when using the reported reference intervalsdespite their shift with agea higher prevalence of anaemia is still detected in the elderly, as exemplified by increasing percentages of abnormal measurements in the input dataset (Fig 4) .
Having established a physiological drop of haemoglobin with increasing age, this leads to a conflict with results from several studies showing an association between anaemia and morbidity and mortality in the elderly (Culleton et al., 2006; Penninx et al., 2006; Lee et al., 2018b; Wouters et al., 2019) . According to these studies, anaemic elderly individuals have an increased risk of death in the following years even after correction of major confounding factors. This holds true if anaemia is defined with age-independent lower limits as suggested by the WHO, but some increase in risk is already observed with haemoglobin concentrations in the low-normal range at least in women (i.e., HB 120-130 g/l). Interestingly, a similar phenomenon was not found in individuals below the age of 60 in one population-based study (Wouters et al., 2019) , but was also observed in younger individuals in another study (Lee et al., 2018b (Lee et al., , 2018a . In 2019, Wouters et al. grouped individuals by the type of anaemia according to additional serum measurements into anaemia of nutritional deficiency (including iron deficiency), anaemia of chronic inflammation, and unexplained anaemia, and found that anaemia of chronic inflammation is strongly correlated with inferior quality of life and increased mortality, whereas the influence of anaemia of other causes is much less pronounced (Wouters et al., 2019) .
Interpreting our findings in the context of the aforementioned reports, we conclude that lower red blood cell-related reference intervals in the elderly are a physiological phenomenon. At the same time, measurements in the sub-normal and low-normal range are linked to decreased quality of life and increased risk of death, probably by correlation rather than by causation. Therefore, it would be prudent to check for a treatable cause of anaemia in elderly individuals with haemoglobin values below 130 g/l (i.e. anaemic or in the low-normal range by current definitions). Intra-individual trends of red blood cell-related analytes in sequential tests may give further information; however, this topic is beyond the scope of this report. If no disease is found, an individual may just have his individual 'set point' in the lower range of the physiologic age-dependent distribution. D1) exclusion according to creatinine and C-reactive protein (CRP), (4., reference intervals D2) exclusion according to CRP, and inclusion only of patients with eGFR (MDRD) ≥ 60 ml/min 9 1Á73 m 2 , and (5., reference intervals D4) combination of all filters/final reference intervals]. See Fig 2 for results in other analytes. .  Table SII . Significance of differences between men and women and extent of differences in reference intervals' 2.5th, 50th, 95.5th percentiles.
